Prospective Relationship Between the Rates of Spontaneous Passage of Distal Ureteral Stones and the Distal Lumen

Ureter Stone Clinical Trial

Official title:

Prospective Observational Evaluation of the Relationship Between the Rates of Spontaneous Passage of Distal Ureteral Stones and the Diameter of the Most Narrow Part of the Distal Ureter

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05416502
• Other study ID #: B.30.2.ATA.0.01.00
• Status: Recruiting
• Start date: January 1, 2021
• Est. completion date: January 1, 2023

Study information

• Verified date: June 2022
• Source: Hiram's Healthcare and Education Company
• Contact: Ozer U Cakici, MD, FEBU
• Phone: +90 541 461 20 51
• Email: ozerural[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Patients (female, male, or queer) with ureteral stones (smaller than 1 cm at the widest diameter of the stone) without pyonephrosis, urinary sepsis, or untraceable pain will be enrolled into the study. Ureteral width at the smallest area of the ureter (in most cases UV junction) will be noted during regular ultrasound scans. The ratio of ureteral width to the stone diameter will be correlated with the spontaneous stone passage.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: January 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Ureteral Stone smaller than 1 cm Volunteer to be enrolled

Exclusion Criteria:

Pyonephrosis Urinary Sepsis Untraceable Pain

Related Conditions & MeSH terms

• Ureter Stone
• Ureteral Calculi
• Ureterolithiasis

Intervention

Procedure:
• Ultrasound
Enrolled patients underwent ultrasound scan of kidneys, ureters, and the bladder.

Locations

Country	Name	City	State
Turkey	Ataturk University	Erzurum

Sponsors (2)

Lead Sponsor	Collaborator
Hiram's Healthcare and Education Company	Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Passage	The number of recruited individuals whose ureteral stones are found to be passed by their report and it is confirmed by ultrasound	3 months